Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
41
NVAX Quote, Financials, Valuation and Earnings
Last price:
$6.86
Seasonality move
:
6.62%
Day range:
$6.59 - $6.85
52-week range:
$5.01 - $11.55
Dividend yield:
0%
P/E ratio:
3.87x
P/S ratio:
1.09x
P/B ratio:
32.13x
Volume:
3.4M
Avg. volume:
3.9M
1-year change:
-18.67%
Market cap:
$1.1B
Revenue:
$682.2M
EPS (TTM):
$1.77
Analysts' Opinion
-
Consensus RatingNovavax, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $12.67, Novavax, Inc. has an estimated upside of 85.19% from its current price of $6.84.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $6.84.
Fair Value
-
According to the consensus of 7 analysts, Novavax, Inc. has 85.19% upside to fair value with a price target of $12.67 per share.
NVAX vs. S&P 500
-
Over the past 5 trading days, Novavax, Inc. has overperformed the S&P 500 by 2.23% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Novavax, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Novavax, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Novavax, Inc. reported revenues of $70.4M.
Earnings Growth
-
Novavax, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Novavax, Inc. reported earnings per share of -$1.25.
Enterprise value:
588.9M
EV / Invested capital:
6.23x
Price / LTM sales:
1.09x
EV / EBIT:
1.41x
EV / Revenue:
0.55x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.53x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
1.30x
Gross Profit (TTM):
$964.5M
Return On Assets:
23.98%
Net Income Margin (TTM):
32.1%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
-112.72%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1B | $885.2M | $1.1B | $84.5M | $70.4M | |
| Gross Profit | $692.2M | $592.6M | $964.5M | $25.7M | $50.6M | |
| Operating Income | -$612.2M | -$290M | $416.7M | -$129.8M | -$79.4M | |
| EBITDA | -$574M | -$243.2M | $451.7M | -$117.1M | -$72.8M | |
| Diluted EPS | -$6.38 | -$2.26 | $1.77 | -$0.76 | -$1.25 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.2B | $1.8B | $1B | $1.1B | $974.6M | |
| Total Assets | $2.6B | $2.3B | $1.7B | $1.7B | $1.2B | |
| Current Liabilities | $1.8B | $1.7B | $1.5B | $1.2B | $429.9M | |
| Total Liabilities | $2.1B | $2.8B | $2.3B | $2.2B | $1.3B | |
| Total Equity | $461.3M | -$566M | -$678.4M | -$526.4M | -$156.7M | |
| Total Debt | $430.7M | $438.1M | $222.1M | $233.3M | $251.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$658.6M | -$90.9M | -$378.3M | -$144.8M | $107.8M | |
| Cash From Investing | -$71.8M | -$357.1M | $45.3M | $31.9M | -$136.5M | |
| Cash From Financing | $99.1M | $364.4M | $30.9M | -$97K | $42.4M | |
| Free Cash Flow | -$730.4M | -$112.3M | -$384.7M | -$146.8M | $105.8M | |
NVAX
Sector
Market Cap
$1.1B
$28.4M
Price % of 52-Week High
59.22%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
0.11%
-1.32%
1-Year Price Total Return
-18.67%
-22.19%
Beta (5-Year)
2.305
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$6.74
200-day SMA
Sell
Level
$7.44
Bollinger Bands (100)
Sell
Level
7.04 - 8.78
Chaikin Money Flow
Sell
Level
-516.2M
20-day SMA
Sell
Level
$6.92
Relative Strength Index (RSI14)
Sell
Level
43.37
ADX Line
Sell
Level
29.74
Williams %R
Neutral
Level
-44.1048
50-day SMA
Sell
Level
$7.95
MACD (12, 26)
Sell
Level
-0.35
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
590M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.0986)
Sell
CA Score
(Annual)
Level (-4.9913)
Buy
Beneish M-Score
(Annual)
Level (-3.5262)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (7.2889)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Stock Forecast FAQ
In the current month, NVAX has received 5 Buy ratings 1 Hold ratings, and 1 Sell ratings. The NVAX average analyst price target in the past 3 months is $12.67.
-
Where Will Novavax, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Novavax, Inc. share price will rise to $12.67 per share over the next 12 months.
-
What Do Analysts Say About Novavax, Inc.?
Analysts are divided on their view about Novavax, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Novavax, Inc. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is Novavax, Inc.'s Price Target?
The price target for Novavax, Inc. over the next 1-year time period is forecast to be $12.67 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 1 rates the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is NVAX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Novavax, Inc. is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NVAX?
You can purchase shares of Novavax, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Novavax, Inc. shares.
-
What Is The Novavax, Inc. Share Price Today?
Novavax, Inc. was last trading at $6.86 per share. This represents the most recent stock quote for Novavax, Inc.. Yesterday, Novavax, Inc. closed at $6.84 per share.
-
How To Buy Novavax, Inc. Stock Online?
In order to purchase Novavax, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NVAX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NVAX
Sector
P/E ratio
3.87x
23.66x
PEG ratio
--
-0.01x
P/B ratio
32.13x
1.84x
Price / LTM sales
1.09x
1.60x
Growth Metrics
NVAX
Sector
Revenue growth
-16.65%
4.85%
Earnings growth
-64.47%
11.15%
Revenue (5-year growth)
105.39%
6.45%
Earnings forecast
-$1.13
-$0.20
Profitability
NVAX
Sector
Profitability FY 2024
$484.2M
$3.6M
Return on invested capital
--
-30.98%
Return on assets
23.98%
-27.62%
Return on equity
--
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
NVAX
Sector
Total cash
$773.7M
$27.2M
Short term investments
$392.9M
$25.7M
Total assets
$1.6B
$79.9M
Long term debt
$251.1M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
